amofit S

Wearable for Sleep and Healthy Aging

8 followers

The world's smallest bioelectronic wearable device uses mild electric currents to stimulate the vagus nerve. From regulating sleep patterns to reducing anxiety and stress levels, and more. Clinically approved. 30 minutes a day. First results under 72 hours.
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Amofit S gallery image
Payment Required
Launch tags:
Productivity•Hardware•Crowdfunding
Launch Team

What do you think? …

Minkyu Kim
Hello Product hunters, We are AMO Lab team. Today we would like to introduce to you our new product — amofit S. Back in 2012, a group of scientists from the University of Illinois at Urbana-Champaign formed a research team. We worked together for over 4 years and founded our own biotechnology company, Amo Lab. We have offices in both the United States and South Korea, where we test all our products. After the successful development and launch of our first "child' — AMO+, we decided to focus on developing a new product that would be even more user-friendly, and effective and would incorporate all the feedback and suggestions from our previous users. Meet amofit S, the world’s smallest bioelectronic wearable device that uses mild electric currents to stimulate the vagus nerve. It doesn’t need to be attached to the skin - you can either clip it to your clothes or wear it as a necklace. The vagus nerve is responsible for a lot of things, like controlling our heart rate, digestion, and breathing. It's also responsible for our mood and emotions. So it's no wonder that when the vagus nerve is functioning properly, we feel good emotionally and physically. But when it's not, we can experience a wide range of problems, like anxiety, depression, fatigue, and even autoimmune diseases. By sending electric currents to the vagus nerve, amofit S improves sleep, stress, and anxiety by restoring the balance of the autonomic nervous system. Its electromagnetic signal passes through the skin, muscles, and bones without any interference. It then is transmitted to the vagus nerve in the chest area. amofit S has two healing modes: CALM and FOCUS. Depending on the need you can change between the modes with a single push of a button. CALM mode is designed to improve sleep, stress, and anxiety and correct the body's internal balance, while FOCUS mode enhances memory and boosts creativity. You can either attach the device to your collar using the device's clip or wear it like a necklace around your neck. 'amofit S' has been tested against the US FCC, European CE, and Korean KC directives and meets safety requirements. Furthermore, we've proven its safety in three clinical trials conducted at KRISS (Korea Research Institute of Standards and Science) and Kyunghee University Hospital. We already have tested the product with 10 000 individuals. We are confident that amofit S will help many people around the world to feel better emotionally and physically. amofit S is currently available for pre-order on Indiegogo. I am open to answering any questions related to amofit S and our activities.
Karen Vardanyan
Great product, helps me stay focused!
Wessel Grift
I'm a bit skeptical. Would love to see this work, but curious to see the scientific concept behind this. As far as I am aware there is no robust/proven correlation between vagal tone and HRV. In fact, the opposite was recently found in rats?
Minkyu Kim
@wessel_grift1 The conclusion regarding vagus nerve-mediated HRV in animal studies are still incomplete, and before addressing mechanistic hypothesis, it is of foremost importance to determine whether mouse models are suitable for the cardiac ANS changes that characterize the natural aging process in humans. Moreover, although human HRV is thought to be primarily regulated by influences of the vagus nerve, a discussion of the specificity of commonly used time-domain and frequency-domain indices of HRV to capture the function of cardiac ANS modulation in mice is still incomplete. This is associated with the significantly higher heart rate and respiratory rate that characterize mice compared to humans, which may affect the proper computation of HRV.